About the authors

Erin Jungmeyer

Managing Editor, ILCN

Mary J. Fidler, MD

Dr. Fidler is Medical Oncology section chief and professor, Department of Internal Medicine, Division of Hematology, Oncology and Cell Therapy, at RUSH Medical College, Chicago.

Jill Feldman, MA

Ms. Feldman is a cofounder of the patient advocacy group the EGFR Resisters.

Related Articles